Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
Item request has been placed!
×
Item request cannot be made.
×
![loading](/sites/all/modules/hf_eds/images/loading.gif)
Processing Request
-
Authors :
Alshehri AM; Department of Pharmacy Practice, College of Pharmacy, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Saudi Arabia.; King Abdulaziz Medical City, National Guard Health Affairs, Riyadh, Saudi Arabia.
Subjects: Acute Kidney Injury*/Acute Kidney Injury*/Acute Kidney Injury*/mortality ; Acute Kidney Injury*/Acute Kidney Injury*/Acute Kidney Injury*/chemically induced ; Piperacillin, Tazobactam Drug Combination*/Piperacillin, Tazobactam Drug Combination*/Piperacillin, Tazobactam Drug Combination*/adverse effects
-
Source:
BMC infectious diseases [BMC Infect Dis] 2025 Jan 07; Vol. 25 (1), pp. 36. Date of Electronic Publication: 2025 Jan 07.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334
تفاصيل العنوان
-
Authors :
Barzilai A; Department of Dermatology, Sheba Medical Center, Tel-HaShomer, Ramat-Gan, Tel Aviv University, Tel Aviv, Israel.; Institute of Pathology, Sheba Medical Center, Ramat-Gan, Israel.
Subjects: Hidradenitis Suppurativa*/Hidradenitis Suppurativa*/Hidradenitis Suppurativa*/drug therapy ; Piperacillin, Tazobactam Drug Combination*/Piperacillin, Tazobactam Drug Combination*/Piperacillin, Tazobactam Drug Combination*/therapeutic use ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/therapeutic use
-
Source:
The Journal of dermatological treatment [J Dermatolog Treat] 2024 Dec; Vol. 35 (1), pp. 2363318. Date of Electronic Publication: 2024 Aug 05.Publisher: Informa Healthcare Country of Publication: England NLM ID: 8918133 Publication Model: Print-Electronic Cited Medium: Internet ISSN:
تفاصيل العنوان
-
Authors :
Mangal V; Department of Internal Medicine, Military Hospital, Ambala, Haryana, India.; Singh R
Subjects: Piperacillin, Tazobactam Drug Combination*/Piperacillin, Tazobactam Drug Combination*/Piperacillin, Tazobactam Drug Combination*/therapeutic use ; Piperacillin, Tazobactam Drug Combination*/Piperacillin, Tazobactam Drug Combination*/Piperacillin, Tazobactam Drug Combination*/adverse effects ; Anti-Bacterial Agents*/Anti-Bacterial Agents*/Anti-Bacterial Agents*/adverse effects
-
Source:
Indian journal of pharmacology [Indian J Pharmacol] 2024 Mar 01; Vol. 56 (2), pp. 144-145. Date of Electronic Publication: 2024 Apr 30.Publisher: Medknow Publications Country of Publication: India NLM ID: 7902477 Publication Model: Print-Electronic Cited Medium: Internet ISSN:
تفاصيل العنوان
-
Source:
Piperacillin Tazobactam Versus Meropenem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae- a
تفاصيل العنوان
-
Source:
Pharmacokinetics and Pharmacodynamic (PK/PD) of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of
تفاصيل العنوان
-
Source:
A Phase III Multicenter, Open Label Randomized Controlled Trial of Cefoxitin Versus Piperacillin-Tazobactam as Surgical Antibiotic
تفاصيل العنوان
-
Authors :
Benoit Crevier, Principal Investigator
-
Source:
Evaluation of the Achievement of a Pharmacodynamic Target of Piperacillin-Tazobactam for the Population with Obesity: an Open Randomized
تفاصيل العنوان
-
Source:
Antimicrobial Therapy for Ventilator-associated Pneumonia Among Patients Colonized With Extended-spectrum Beta-lactamase-producing Enterobacteriaceae : Efficacy of a Strategy Using
تفاصيل العنوان